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Abstract Schizophrenia is one of the major psychiatric
disorders, and lipids have focused on the important roles in
this disorder. In fact, lipids related to various functions in
the brain. Previous studies have indicated that phospholi-
pids, particularly ones containing polyunsaturated fatty acyl
residues, are deficient in postmortem brains from patients
with schizophrenia. However, due to the difficulties in
handling human postmortem brains, particularly the large
size and complex structures of the human brain, there is
little agreement regarding the qualitative and quantitative
abnormalities of phospholipids in brains from patients with
schizophrenia, particularly if corresponding brain regions
are not used. In this study, to overcome these problems, we
employed matrix-assisted laser desorption/ionization imag-
ing mass spectrometry (IMS), enabling direct microregion
analysis of phospholipids in the postmortem brain of a
patient with schizophrenia via brain sections prepared on
glass slides. With integration of traditional histochemical
examination, we could analyze regions of interest in the
brain at the micrometric level. We found abnormal
phospholipid distributions within internal brain structures,
namely, the frontal cortex and occipital cortex. IMS
revealed abnormal distributions of phosphatidylcholine
molecular species particularly in the cortical layer of frontal
cortex region. In addition, the combined use of liquid
chromatography/electrospray ionization tandem mass spec-
trometry strengthened the capability for identification of
numerous lipid molecular species. Our results are expected
to further elucidate various metabolic processes in the
neural system.
Keywords Schizophrenia . Postmortem brain . Imaging
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Introduction
Schizophrenia is one of the major psychiatric disorders,
producing symptoms such as hallucinations and delusions
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[1]. Despite considerable worldwide research for over a
century, the etiology of this illness remains incompletely
understood. There are several hypotheses regarding the
cause of schizophrenia, and a widely accepted one is the
neurotransmitter hypothesis, which involves abnormal
synaptic functions due to defects in neurotransmitter
regulation, including their production, release, reuptake,
and reception by neurotransmitter receptors [2]. Since the
neuronal membrane is an important structural and func-
tional site for the receptors, identification of neural lipid
abnormalities in postmortem brains of schizophrenia
patients has been also intensively pursued.
In the central nervous system, phospholipids are the
most abundant lipids. They comprise a molecular family in
which phosphoric acid is present in the ester form. Some
classes of phospholipids are structurally distinct based on
the head group linked to the phosphate attached at the sn-3
position of the glycerol backbone, such as phosphatidylcho-
lines (PCs) and phosphatidylinositols (PIs). Depending on
the compositions of the two fatty acyl residues linked at the
sn-1 and sn-2 positions, phospholipids of the same class are
further subdivided into molecular species. In particular,
regarding stored fatty acyl residues in the phospholipids,
polyunsaturated fatty acyl residues have been paid special
attention in schizophrenia research because they are
essential to maintaining normal membrane structure and
function as well as to normal brain development [3]. Two
types of PUFAs, the n-6 and n-3 series, primarily arach-
idonic acid [arachidonate, 20:4(n-6)] and docosahexaenoic
acid [DHA, 22:6(n-3)], are designated by the location of the
first double bond from the methyl group (see also Electronic
Supplementary Material Fig. S1).
So far, the combined use of thin-layer chromatography
(TLC) and gas chromatography (GC) has been widely adapted
for analyzing lipids in schizophrenia research, which allows
the separation of each phospholipid class by TLC, and then
quantifying the fatty acid composition of each phospholipid
class by GC. In early researches, Horrobin et al. reported
defects in the fatty acid composition of phosphatidylethanol-
amines (PEs), particularly in the frontal cortex of patients with
schizophrenia [4]. More recently, Schmitt et al. [5] reported
decreased PCs and sphingomyelin (SMs) levels and increased
phosphatidylserine (PS) levels in the thalamus. Further,
McNamara et al. reported decreased DHA and vaccenic acid
levels in the orbitofrontal cortex [6, 7]. Mass spectrometry
(MS) has been widely adopted in relatively recent schizo-
phrenia research. By using LC-MS, Schwarz et al. reported
that PCs and free fatty acids are increased in the frontal cortex
of a schizophrenia patient's brain [8].
Despite such intensive studies, however, considerable
disagreements exist regarding the qualitative and quantitative
abnormalities of lipids in the brains from patients with
schizophrenia. For example, Shimon et al. revealed that PI
levels are decreased in the postmortem brain of patients [9];
however, Shapiro found no difference in the PI amount by
the same method [10]. Hamazaki et al. reported that n-3 fatty
acids such as DHA were not remarkably altered but that n-6
fatty acids, such as arachidonic acid, were decreased in the
hippocampus of brains from schizophrenia and bipolar
disorder patients [11]. On the other hand, a study focusing
on the orbitofrontal area reported a 20% decrease in DHA in
schizophrenia patients [6]. Although several well-recognized
reasons lead to variations in the experimental results of
postmortem human samples, i.e., ethnogenesis, personal
drug and disease history, and postmortem time, the above-
mentioned cases clearly indicate the importance of control-
ling experiments by using strictly corresponding brain
regions. In fact, current lipid studies, including those by
our group, demonstrate that brain lipids are distributed in a
heterogeneous pattern even within small brain regions [12–
14]; therefore, careful and precise dissection techniques are
required in such studies, particularly when employing
traditional biochemical methods.
Here, we utilized matrix-assisted laser desorption/ioniza-
tion imaging mass spectrometry (MALDI-IMS) for regional
analysis of lipids on brain tissue sections. In this emerging
imaging technology, tissue sections were directly scanned by
MALDI laser, and mass spectra were recorded for each data
point. Based on the ion intensities obtained from each tissue
location, two-dimensional distribution maps for multiple
lipids could be simultaneously obtained through one mea-
surement [15]. The current spatial resolution of IMS, as
defined by laser diameter and accuracy of sample stage
movement [16], could examine tissues at micrometric level
[17]; we could also directly conduct lipid quantification from
microregions on the postmortem brain sections. Furthermore,
analyzed tissue sections could be histochemically stained;
therefore, the obtained lipid distribution maps could be
integrated to traditional histochemical images, thus precisely
recognizing the part of brain being analyzed.
In this study, we revealed abnormal PC distributions within
internal brain structures, namely, the frontal cortex and
occipital cortex of a postmortem brain from a patient with
schizophrenia. In addition, the combined use of the LC
electrospray ionization tandem mass spectrometry (LC/ESI-
MS/MS) system strengthened the capability of the technique
for molecular identification.
Materials and methods
Human brain The human brain samples including prefron-
tal cortex and occipital cortex were obtained following the
protocols approved by the Fukushima Medical University.
The postmortem brain of a patient with schizophrenia was
supplied by the Postmortem Brain Bank of Fukushima for
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Psychiatric Research. This Brain Bank specializes in
psychiatric diseases in Japan. The patient with schizophre-
nia was a 70-year-old male, and the postmortem interval
was 18 h. An age- and sex-matched normal sample was
obtained from the Choju Medical Institute, Fukushimura
Hospital, Toyohashi. The patient characteristics are indicated
in Table 1. Informed written consent was obtained from the
families of both subjects. The patient with schizophrenia
fulfilled the diagnostic criteria established by the American
Psychiatric Association (Diagnostic and Statistical Manual
of Mental Disorders (DSM-IV)).
Chemicals Methanol, potassium acetate, and ultra pure
water were purchased from Wako Chemical (Osaka, Japan).
Calibration standard peptide and 2,5-dihydroxybenzoic acid
(DHB) were purchased from Bruker Daltonics (Leipzig,
Germany). All the chemicals used in this study were of the
highest purity available. 9-Aminoacridine was purchased
from Acronics (Pittsburgh, PA, USA). 1-Palmitoyl-2-oleyl-
sn-glycero-3-phosphate, PC (diacyl-16/0:18:1), was pur-
chased from Funakoshi Co. Ltd. (Tokyo, Japan).
Tissue section preparation for IMS and ESI-MS/MS Tissues
blocks were sectioned at −18 °C using a cryostat (CM
1950; Leica, Germany) to a thickness of 8 μm, as described
in previous reports [18, 19]. Although brain blocks were
held by an optimum cutting temperature (OCT) polymer,
they were not embedded in it because it was considered that
any residual polymer on the tissue slices might degrade the
mass spectra [19]. The frozen sections were thaw-mounted
on indium-tin-oxide (ITO)-coated glass slides (Bruker
Daltonics). For LC/ESI-MS/MS, several sections were
collected into glass vials for lipid extraction (approximately
10 mg for each), and total lipids were extracted by the
Folch method [20].
Sample preparation for LC/ESI-MS/MS The ESI-MS/MS
analysis was performed using a 4000Q-TRAP quadrupole
linear ion trap hybrid mass spectrometer (Applied Biosystems/
MDS Sciex, Concord, ON, Canada) with an ACQUITY Ultra
Performance Liquid Chromatography (LC; Waters, Milford,
MA, USA).
A chromatographic method was developed using an
ACQUITY UPLCTM BEH C18 column (2.1×50 mm i.d.,
1.7-μm particle), fitted with an identically packed guard
column (2.1×5 mm; Waters, Milford, MA, USA). The
column oven was maintained at 40 °C. The following gradient
elution with mobile phase A (acetonitrile:methanol:water=
19:19:2 v/v/v, containing 0.1% formic acid and 0.028%
ammonia) and mobile phase B (isopropanol, 0.1% formic
acid, and 0.028% ammonia) was used at a flow rate of
0.4 mL/min:0–10 min:5% B→5% B; 10–15 min:5% B→
50% B; 15–20 min:50% B→50% B, and 20–25 min:5% B.
Precursor ion and neutral loss scanning for specific
phospholipid classes To identify the specific phospholipid
classes, precursor ion scanning of the polar head group of
PCs and SMs (m/z184), and neutral loss scan of that of PE
(m/z141) were performed using the 4000Q-TRAP instru-
ment; these methods are effective for detecting PCs because
characteristic fragment ions are generated by collision-
induced dissociation (CID) [21]. The level of collision
energy is very important to the sensitive identification of
focused molecules; therefore, optimal conditions for detect-
ing the appropriate precursor ion and neutral loss were
determined by preliminarily analyzing PC (diacyl-16:0/
18:1) as standard lipid.
Spray coating of the matrix solution for IMS A DHB
solution (40 mg/mL DHB, 20 mM potassium acetate, 70%
MetOH, 0.1% TFA) was used as the matrix solution for
imaging the PCs. Here, 9-aminoacridine (10 mg/mL,
dissolved in 70% methanol) was used for imaging the
PEs. The matrix solution was sprayed over the tissue
surface using a 0.2-mm nozzle caliber airbrush (Procon Boy
FWA Platinum; Mr. Hobby, Tokyo, Japan). Tissue sections
that were to be compared were simultaneously spray-coated
with each matrix solution to equalize analyte extraction and
co-crystallization conditions. The distance between the
nozzle tip and the tissue surface was 10 cm, and the
spraying period was fixed at 5 min. Approximately 100 μL
of matrix solution was sprayed onto each brain section.
IMS conditions (single MS imaging) Single MS imaging
was performed using a MALDI TOF/TOF-type instrument
(Ultraflex 2 TOF/TOF; Bruker Daltonics). This instrument
was equipped with a 355-nm Nd:YAG laser. The data were
acquired in the positive reflectron mode under an acceler-
Schizophrenia Normal control
Age at death 74 73
Gender Male Male
Cause of death Pneumonia and heart failure Pneumonia and acute myocardial infarction
Brain hemisphere Left Left
Postmortem interval 18 h 2 h
Table 1 Demographic informa-
tion for subject with schizo-
phrenia and matched control
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ating potential of 20 kV using an external calibration
method. Signals between m/z400 and 1,000 were collected.
Raster scans on tissue surfaces were performed automati-
cally using FlexControl and FlexImaging 2.0 software
(Bruker Daltonics). The number of laser irradiations was
200 shots in each spot. Image reconstruction was performed
using FlexImaging 2.0 software.
MS/MS and MS/MS imaging Molecular identification was
performed with LTQ-XL (Thermo Fisher Scientific)
equipped with an intermediate-pressure MALDI ion source.
Since the ions corresponding to PEs contain multiple ions
within the same nominal mass, we performed MS/MS
imaging with LTQ-XL at a raster scan pitch of 40 μm in
negative ion detection mode. Image reconstruction was
performed using Image Quest (Thermo Fisher Scientific).
Data analysis of IMS We extracted the spectra in about 200
data point from gray matter by FlexImaging 2.0 software
(Bruker Daltonics), and the intensities of assigned mass
peaks were quantitated by FlexAnalysis 3.0 software
(Bruker Daltonics). To relatively quantitative analyses, the
mean intensity ratio of schizophrenia/normal of each
assigned peaks was calculated in the frontal cortex and
occipital cortex, and p value was calculated by t test using
relative intensities of each data point in gray matter region
to compare mean intensity ratio between schizophrenia and
normal brain. Statistical differences between the data from
the patient with schizophrenia and the control subject were
assessed using an unpaired Student's t test. p<0.01 was
considered to be significant.
Results and discussion
Experimental scheme
Figure 1 shows the experimental scheme employed in this
study. In hospitals, including brain bank-network institutes,
because of the large size and complex structure of human
brains, dissected postmortem brains are generally sectioned
into several blocks and then stored at −80 °C until further
use. In this study, we focused upon the frontal and occipital
parts of the cerebral cortex, particularly because the frontal
cortex region is known to exhibit apparent anatomical
defects in the brains of schizophrenia patients [22, 23].
Frozen brain blocks were thinly sliced, and for LC/ESI-MS/
MS, several sections were collected into glass vials for lipid
extraction. Further, few successive sections were thaw-
mounted on the ITO-coated glass slides for the MALDI
imaging experiment. Total lipids were extracted from the
collected tissues in the vials, and molecular species
compositions of specific phospholipid classes were selec-
tively identified by MS/MS scans, provided by LC/ESI-
MS/MS. Next, MALDI-IMS was performed on the succes-
sive tissue sections, and ion peaks corresponding to the pre-
identified lipid molecular species by LC/ESI-MS/MS were
selected. Since mass spectra obtained by imaging have
spatial information, in the next step, we analyzed only
spectra from corresponding brain regions of the normal
control and patient, although the shapes of the dissected
brain blocks differed considerably. Using mass spectra
extracted only from the frontal and occipital cortex regions,
we identified lipid species whose detected ion intensities
changed between the control and diseased brains. Finally,
Fig. 1 Scheme of experimental procedure employing MALDI-IMS
and LC/ESI-MS/MS for microregion lipid analysis of human
postmortem brain. Dissected postmortem brains were sectioned into
several blocks and then stored at −80 °C until use. Frozen brain blocks
were thinly sliced in the cryo-chamber, and for LC/ESI-MS/MS,
several sections were collected into glass vials for lipid extraction.
Successive sections were then thaw-mounted on the ITO-coated glass
slides for the MALDI imaging experiment. Lipids were extracted, and
the molecular species composition of specific phospholipid classes
was selectively identified by LC/ESI-MS/MS. Based on the identified
molecular species composition, lipid species whose intensities
changed between the control and diseased brains were screened from
the mass spectra obtained from the specified brain region in the
imaging data. Finally, the extracted candidates were confirmed as a
designated lipid species by MS/MS on the tissue section
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for the identified lipid species with abnormal expression
amounts in the patient's brain, we validated them as
designated lipid species by MS/MS of the tissue section.
Identification of individual molecular species of PCs, SMs,
and PEs by LC/ESI-MS/MS
Before conducting MALDI-IMS experiments, we selectively
identified the composition of lipid molecular species, namely,
PCs, SMs, and diacyl-PEs in the total lipid extract from
normal human brain using LC/ESI-MS/MS. By precursor ion
scanning of the choline containing head group, we pre-
identified PC and SMmolecular species; diacyl-PE molecular
species were identified by neutral loss scan of the phosphoe-
thanolamine containing head group (Fig. 2). Such pre-
elucidation of the targeted phospholipid molecular species
was helpful in the IMS data interpretation described later.
Since IMS experiments directly subject tissue section
samples that are complex mixtures of numerous biological
molecules, mass spectra obtained by IMS comprised
hundreds of peaks derived from biological molecules as
well as matrix clusters. In MALDI-IMS, molecular identifi-
cation of such ions one by one is a time-consuming process.
In this study, by pre-identifying the existing lipid molecular
species by LC/ESI-MS/MS, we could pre-define the target
mass peaks in the following IMS data analysis. This would
be particularly important for a study with samples from
human patients because available sample amounts are
severely limited.
For the identification of phospholipids containing the
choline head group, such as PC, lysoPC, and SM species, a
specific fragment at m/z184 (phosphorylcholine) is known
and has been used as a specific target in identifying
choline-containing phospholipids using product ion and
precursor ion scanning methods [24–27]. Figure 2a shows a
two-dimensional (2D) abundance map of PC and SM
molecular species from the human brain obtained by LC/
ESI-MS using the C18 reverse-phase column in the positive
ion detection mode. The 2D map has the m/z value along
the vertical axis and the retention time along the horizontal
axis. The total ion chromatogram and averaged mass
spectra are shown on the upper and left sides of the 2D
map, respectively. When using a reverse-phase column,
PCs and SMs elute in order from the hydrophilic to the
more hydrophobic species. The length of fatty acyl chains
mainly influences the elution order, and the number of
double bonds in fatty acyl chains also influences the elution
order. Based on the m/z value and relative retention time
and previous reports [28, 29], we assigned 17 PC molecular
species and three SM species as abundant PC and SM
molecules in the human brain (Fig. 2b). In the same way,
we also identified 11 diacyl-PE species by neutral loss
scanning of m/z141 (phosphoethanolamine head group),
also in positive ion detection mode (Fig. 2c, d). One thing
we have to note is that plasmalogen-type PE were less
detected by this ESI-MS/MS method (J Am Soc Mass
Spectrom 15(10):[36]). Having obtained qualitative data
regarding molecular identification, we next proceeded to
MALDI-IMS of the normal control and schizophrenia
brains.
Microregion analysis of phospholipid molecular species
in the brain sections
Next, we proceeded to microregion analysis of lipids in the
brain sections from the control subject and the patient with
schizophrenia. First, we performed MALDI-IMS of both
brain sections in the positive ion detection mode. We
employed an optimized experimental condition for PC and
SM detection including composition of matrix solution [14]
in order to selectively analyze PC and SM species. In
particular, potassium salts added to the matrix solution
caused merging of various lipid adducts (adducts with
proton, sodium, and potassium) into one single potassiated
species, thus making IMS data interpretation fairly easy
[30]. After the IMS measurement, applied matrix crystals
were removed by immersing the slides into methanol, and
the tissue sections were stained with hematoxylin and eosin
(HE). Stained sections were then observed by light
microscopy, and based on the obtained microscopic image,
we defined the cerebral cortex region of both sections
(Fig. 3a) and applied them to the IMS data set.
Because of the low availability of postmortem human
brain, it is generally difficult to acquire tissue blocks
containing complete corresponding brain regions. In this
case, the control brain block contained only gray matter
regions, while the brain block from the schizophrenia
patient contained both gray and white matter. We extracted
data only from the corresponding brain areas by the
imaging-based analysis. We defined regions of interest
(ROI) on the frontal and occipital lobes, according to the
microscopic images of HE-stained tissue sections. From the
defined regions of interest, approximately 200 spectra for
each were collected, and mass peaks were detected and then
their intensities were calculated. Electronic Supplementary
Material Fig. S2 shows the representative mass spectrum
obtained; from the numerous mass peaks detected, we
assigned 17 mass peaks as the pre-identified PC and SM
molecular species. Ion intensity values of the 17 ions from
the extracted spectra (800 spectra in total) were calculated
and compared between the control and patient samples.
The results are summarized in Table 2. In the table, the
green cells represent increase in the amount, while red
represents a reduced amount in the patient as compared to
the normal control. Table lines representing each lipid
species are arranged in order of the greatest increasing to
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Fig. 2 Identification of individ-
ual molecular species of focused
phospholipid classes by precur-
sor ion and neutral loss scanning
of their head groups in the
positive ion mode. The extracted
total lipid mixture from the
control postmortem human brain
was subjected to precursor ion
scanning of m/z184 for detec-
tion of PCs and SMs (a, b) and
neutral loss scan of m/z141 for
detection of diacyl form PEs (c,
d). The 2D map (a, c) has the m/
z value along the vertical axis
and the retention time along the
horizontal axis. The total ion
chromatogram and averaged
mass spectra were shown on the
upper and left sides of the 2D
map, respectively. From the 2D
map, the relative ion counts of
each PC, SM, and PE molecule
species were calculated (The
most intense species is shown as
intensity at 1.) Detected PUFAs,
namely, arachidonic acid, DHA,
and docosatetraenoic acid, are
shown as red, orange, and green
characters, respectively
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decreasing trend in the frontal cortex of the patient. PC
(diacyl-16:0/20:4) was the most increased species in the
frontal cortex, while PC (diacyl-16:0/18:1) was the most
reduced species in both the frontal and occipital cortex.
Here, we particularly focused on the molecular species
whose level was significantly altered in the frontal but not
in the occipital cortex because such an abnormal pattern
may reflect anatomical defects that may be attributed to
schizophrenia [22, 23]; this molecule was identified as PC
(diacyl-16:0/20:4).
In Fig. 3b, we have shown the distribution of the PCs. Ion
images are arranged in the same order as in Table 2. These
images demonstrated that each PC and SM molecular
species have a rather heterogeneous distribution pattern even
within cerebral cortex brain blocks, implicating the impor-
tance of precise tissue dissection when employing conven-
tional biochemical analysis. On the other hand, taking
advantage of the imaging analysis, we could adjust accurate
corresponding regions for comparing differently shaped
samples. In Fig. 4a, b, we plotted ion abundances of the
PCs along with the distance from the cortical to the deep
layer of the cerebral cortex. The graphs for PC (diacyl-16:0/
20:4) and PC (diacyl-16:0/18:1) revealed that both—the
increase in PC (diacyl-16:0/20:4) and the reduction in PC
(diacyl-16:0/18:1)—in the patient were particularly observed
in the cortical layer of the cortex (arrows). Regarding the
PEs, since their ionization efficiency was relatively low in
the positive ion detection mode when compared to the
choline-containing lipids, we analyzed these in the negative
detection mode using 9-aminoaciridine as a matrix [31].
Furthermore, to achieve a high detection selectivity, we
performed MS/MS imaging of the PE species for two
abundant pre-identified species because PCs remain detect-
able as −CH3+ ions if 9-aminoaciridine is used as a matrix in
the negative ion detection mode [32]. In fact, as Electronic
Supplementary Material Fig. S3 shows, ions corresponding
to PEs contained several ions other than PE, but we could
successfully visualize PE (diacyl-18:0/22:6) and PE (diacyl-
18:0/22:4) by visualizing ion transition in which specific
fatty acyl residues were produced from their precursor ions
(Fig. 4c and Electronic Supplementary Material Fig. S3),
though significant alteration was not altered.
Finally, we validated the assignments of PC molecular
species by tissue MS/MS, particularly for molecules
demonstrating considerable alteration rates in Table 2.
Figure 5 shows the product ion spectra for the ions
corresponding to the six PC and SM molecules; in each
spectrum, the presence of a choline containing head group
Fig. 3 Visualization of PC distributions showing changes in the
detection intensities between the brains of control and the patient with
schizophrenia. aMicroscopic observation of HE-stained brain sections
analyzed after IMS measurement. b IMS results for brain sections
from control and the patient with schizophrenia
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and phosphate was confirmed. Neutral losses (NL) of 59 and
183 u from precursor ions, corresponding to trimethylamine
and phosphocholine, respectively, were used as diagnostic
ions in product ion mass spectra [33]. Furthermore, we
confirmed detailed fatty acid constituents of each PC by
replacing adducted alkali metal from potassium to lithium,
by adding 20 mM of lithium acetate in the matrix solution
[30]. MS/MS subjecting such lithium-adducted molecules
provides increased acyl-chain loosed fragment ions; there-
fore, we could precisely identify the fatty acid moiety ([NL]
of acyl-chain; see Electronic Supplementary Material
Figs. S4 and S5). Overall, the six molecular species were
identified as PC and SM molecules. On the other hand, the
ion at m/z848 was revealed to contain both PC (diacyl-18:0/
20:4) and galactosylceramide, and therefore, its data was
eliminated from this investigation (data not shown). We also
note regarding lyso-phospholipids; we certainly detected the
lyso-phospholipid species particularly of the lyso-PCs
(LPCs) by both MALDI and ESI-MS. However, since their
amounts are much smaller than diacyl-phospholipids, there-
fore, they are likely to be sensitive to postmortem degrada-
tion. Thus, we here omitted discussion on them.
Table 2 Molecular species of PCs and SMs in order of the increased rate in the frontal cortex from the patient with schizophrenia as compared to
the normal control, as revealed by MALDI-IMS
Molecular weight LC/ESI-MS/MS Rate of increase in frontal cortex compared to
normal
Rate of increase in occipital cortex compared to
normal
Ratio p value Ratio p value
820.53 PC (diacyl-16:0/20:4) 1.32 <0.01 1.09 <0.01
797.59 SM (20:0) 1.26 <0.01 1.30 <0.01
744.49 PC (diacyl-16:0/14:0) 1.18 <0.01 1.13 <0.01
796.53 PC (diacyl-16:0/18:2) 1.12 <0.01 1.02 0.21
770.51 PC (diacyl-16:0/16:1) 1.10 <0.01 0.95 0.01
846.54 PC (diacyl-18:1/20:4) 1.08 <0.01 1.08 <0.01
772.53 PC (diacyl-16:0/16:0) 1.07 0.01 0.84 <0.01
844.53 PC (diacyl-16:0/22:6) 1.03 0.14 1.04 0.04
870.54 PC (diacyl-18:1/22:6) 1.00 0.95 1.27 <0.01
848.56 PC (diacyl-18:0/20:4) 0.99 0.57 0.77 <0.01
826.57 PC (diacyl-18:0/18:1) 0.98 0.39 0.93 <0.01
769.56 SM (18:0) 0.98 0.30 0.82 <0.01
872.56 PC (diacyl-18:0/22:6) 0.97 0.04 1.13 <0.01
800.56 PC (diacyl-16:0/18:0) 0.97 0.06 0.86 <0.01
824.56 PC (diacyl-18:1/18:1) 0.94 <0.01 0.85 <0.01
822.54 PC (diacyl-16:0/20:3) 0.94 <0.01 0.94 <0.01
798.54 PC (diacyl-16:0/18:1) 0.86 <0.01 0.75 <0.01
These molecular species were identified by LC/ESI-MS/MS
Fig. 4 Regional analysis of PC
and PE molecular species in the
cerebral cortex of postmortem
human brains. In-depth analyses
of the most increased PCs (16:0/
20:4) (a) and the most decreased
one (16:0/18:1) (b), and PE
(18:0/22:6) (c). Plots of ion
abundances of the PCs and PE
along with the distance from the
cortical to the deep layer of the
cerebral cortex, demonstrating
that the cortical layer showed
maximal changes in the lipid
contents (arrows)
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Lipid analysis linked to brain functional mapping
in postmortem human brains
Through this study, we found that PC (diacyl-16:0/20:4)
containing arachidonic acid was increased in the prefrontal
cortex of the patient with schizophrenia; no such increase
was found in the occipital cortex. As mentioned above, we
particularly focused on the molecular species whose level
showed a significant alteration in the frontal but not in the
occipital cortex because such a defect pattern may reflect
Fig. 5 On tissue MS/MS of molecules showing considerably changed
ratios. In each mass spectrum, the presence of a choline containing
head group and phosphate was confirmed (neutral losses [NL] of 59
and 183 u from precursor ions, corresponding to trimethylamine and
trimethylamine with cyclophosphate, respectively); these were used as
the diagnostic ions in product ion mass spectra [33]
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the anatomical defects attributable to schizophrenia [22,
23]. Our finding agrees with those of a previous study by
McNamara et al. who found that among male schizophrenia
patients, the arachidonic acid:DHA ratio was increased in
the frontal cortex [6].
Our methodology in this study had the specific advan-
tage of enabling small-region analysis of lipid molecular
species along with spatial information. This could uncover
abnormalities in local lipid metabolism within postmortem
human brains. Each region of the human brain cortex is
known to have heterogeneous functions, especially high-
level ones, including social skills for communication [34].
Since schizophrenia patients exhibit abnormalities in such
higher function, it is particularly important to link previous
biochemical analyses—including lipid analyses—to brain
functional mapping. We propose that our methodology
would enable such evaluation. Although the present study
is only a feasibility study, we are currently conducting
large-scale case-control studies using postmortem brains
provided by our brain bank network [35].
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
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